ClinicalTrials.gov record
Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women
ClinicalTrials.gov ID: NCT03475706
Public ClinicalTrials.gov record NCT03475706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Oral Solabegron Immediate Release Tablets in the Treatment of Overactive Bladder (OAB) in Adult Female Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy, safety, and tolerability of solabegron immediate release low dose or high dose tablets, compared to matched placebo, administered twice daily for 12 weeks to adult female subjects with overactive bladder symptoms (frequency, urgency, and predominantly urgency incontinence) for at least 6 months.
Study identification
- NCT ID
- NCT03475706
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 438 participants
Conditions and interventions
Conditions
Interventions
- Solabegron immediate release tablets, low dose Drug
- Solabegron immediate release tablets, high dose Drug
- Matching Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 19, 2018 (Actual)
- Primary completion
- Jan 24, 2019 (Actual)
- Completion
- Jan 30, 2019 (Actual)
- Last update posted
- Mar 2, 2020
2018 – 2019
United States locations
- U.S. sites
- 86
- U.S. states
- 32
- U.S. cities
- 80
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velicept Investigative Site - Birmingham | Birmingham | Alabama | 35205 | — |
| Velicept Investigative Site - Gulf Shores | Gulf Shores | Alabama | 36542 | — |
| Velicept Investigative Site - Mobile | Mobile | Alabama | 36608 | — |
| Velicept Investigative Site - Tempe | Tempe | Arizona | 85283 | — |
| Velicept Investigative Site - Tucson | Tucson | Arizona | 87504 | — |
| Velicept Investigative Site - Little Rock | Little Rock | Arkansas | 72212 | — |
| Velicept Investigative Site - Anaheim | Anaheim | California | 92801 | — |
| Velicept Investigative Site - Arcadia | Arcadia | California | 91007 | — |
| Velicept Investigative Site - Canoga Park | Canoga Park | California | 91303 | — |
| Velicept Investigative Site - Huntington Beach | Huntington Beach | California | 92647 | — |
| Velicept Investigative Site - Los Alamitos | Los Alamitos | California | 90720 | — |
| Velicept Investigative Site - Los Angeles | Los Angeles | California | 90017 | — |
| Velicept Investigative Site - Norco | Norco | California | 92860 | — |
| Velicept Investigative Site - Sacramento | Sacramento | California | 95821 | — |
| Velicept Investigative Site - San Diego | San Diego | California | 92103 | — |
| Velicept Investigative Site - San Diego | San Diego | California | 92123 | — |
| Velicept Investigative Site - San Marcos | San Marcos | California | 92078 | — |
| Velicept Investigative Site - Thousand Oaks | Thousand Oaks | California | 91360 | — |
| Velicept Investigative Site - Denver | Denver | Colorado | 80209 | — |
| Velicept Investigative Site - Waterbury | Waterbury | Connecticut | 06708 | — |
| Velicept Investigative Site - Clearwater | Clearwater | Florida | 33761 | — |
| Velicept Investigative Site - Deland | DeLand | Florida | 32720 | — |
| Velicept Investigative Site - Doral | Doral | Florida | 33166 | — |
| Velicept Investigative Site - Jupiter | Jupiter | Florida | 33458 | — |
| Velicept Investigative Site - Lake City | Lake City | Florida | 32055 | — |
| Velicept Investigative Site - Miami | Miami | Florida | 33135 | — |
| Velicept Investigative Site - Miami | Miami | Florida | 33176 | — |
| Velicept Investigative Site - Miami | Miami | Florida | 33186 | — |
| Velicept Investigative Site - Ponte Vedra | Ponte Vedra | Florida | 32081 | — |
| Velicept Investigative Site - Port St Lucie | Port Saint Lucie | Florida | 34952 | — |
| Velicept Investigative Site - West Palm Beach | West Palm Beach | Florida | 33409 | — |
| Velicept Investigative Site - Winter Haven | Winter Haven | Florida | 33880 | — |
| Velicept Investigative Site - Marietta | Marietta | Georgia | 30060 | — |
| Velicept Investigative Site - Blackfoot | Blackfoot | Idaho | 83221 | — |
| Velicept Investigative Site - Meridian | Meridian | Idaho | 83642 | — |
| Velicept Investigative Site - Wauconda | Wauconda | Illinois | 60084 | — |
| Velicept Investigative Site - Elwood | Elwood | Indiana | 46036 | — |
| Velicept Investigative Site - Evansville | Evansville | Indiana | 47714 | — |
| Velicept Investigative Site - Newton | Newton | Kansas | 67114 | — |
| Velicept Investigative Site - Louisville | Louisville | Kentucky | 40291 | — |
| Velicept Investigative Site - Metairie | Metairie | Louisiana | 70001 | — |
| Velicept Investigative Site - New Orleans | New Orleans | Louisiana | 70115 | — |
| Velicept Investigative Site - Shreveport | Shreveport | Louisiana | 71106 | — |
| Velicept Investigative Site - Boston | Boston | Massachusetts | 02131 | — |
| Velicept Investigative Site - New Bedford | New Bedford | Massachusetts | 02740 | — |
| Velicept Investigative Site - North Attleborro | North Attleboro | Massachusetts | 02760 | — |
| Velicept Investigative Site - Watertown | Watertown | Massachusetts | 02472 | — |
| Velicept Investigative Site - Kalamazoo | Kalamazoo | Michigan | 49009 | — |
| Velicept Investigative Site - St. Louis | St Louis | Missouri | 63141 | — |
| Velicept Investigative Site - Omaha | Omaha | Nebraska | 68114 | — |
| Velicept Investigative Site - Las Vegas | Las Vegas | Nevada | 89119 | — |
| Velicept Investigative Site - Brick | Brick | New Jersey | 08724 | — |
| Velicept Investigative Site - Vorhees | Voorhees Township | New Jersey | 08043 | — |
| Velicept Investigative Site - Albuquerque | Albuquerque | New Mexico | 87102 | — |
| Velicept Investigative Site - New York | New York | New York | 10016 | — |
| Velicept Investigative Site - Williamsville | Williamsville | New York | 14221 | — |
| Velicept Investigative Site - Charlotte | Charlotte | North Carolina | 28203 | — |
| Velicept Investigative Site - Wilmington | Wilmington | North Carolina | 28401 | — |
| Velicept Investigative Site - Winston-Salem | Winston-Salem | North Carolina | 27103 | — |
| Velicept Investigative Site - Cincinnati | Cincinnati | Ohio | 45236 | — |
| Velicept Investigative Site - Cleveland | Cleveland | Ohio | 44122 | — |
| Velicept Investigative Site - Columbus | Columbus | Ohio | 43123 | — |
| Velicept Investigative Site - Marion | Marion | Ohio | 43302 | — |
| Velicept Investigative Site - Middleburg Heights | Middleburg Heights | Ohio | 44130 | — |
| Velicept Investigative Site - Warwick | Warwick | Rhode Island | 02818 | — |
| Velicept Investigative Site - Mt. Pleasant | Mt. Pleasant | South Carolina | 29464 | — |
| Velicept Investigative Site - Myrtle Beach | Myrtle Beach | South Carolina | 29572 | — |
| Velicept Investigative Site - Jackson | Jackson | Tennessee | 38305 | — |
| Velicept Investigative Site - Knoxville | Knoxville | Tennessee | 37920 | — |
| Velicept Investigative Site - Nashville | Nashville | Tennessee | 37203 | — |
| Velicept Investigative Site - Austin | Austin | Texas | 78735 | — |
| Velicept Investigative Site - Beaumont | Beaumont | Texas | 77702 | — |
| Velicept Investigative Site - Lampasas | Lampasas | Texas | 76550 | — |
| Velicept Investigative Site - Longview | Longview | Texas | 80209 | — |
| Velicept Investigative Site - San Antonio | San Antonio | Texas | 78209 | — |
| Velicept Investigative Site - San Antonio | San Antonio | Texas | 78229 | — |
| Velicept Investigative Site - San Antonio | San Antonio | Texas | 78249 | — |
| Velicept Investigative Site - Clinton | Clinton | Utah | 84015 | — |
| Velicept Investigative Site - Salt Lake City | Salt Lake City | Utah | 84107 | — |
| Velicept Investigative Site - Salt Lake City | Salt Lake City | Utah | 84124 | — |
| Velicept Investigative Site - St. George | St. George | Utah | 84790 | — |
| Velicept Investigative Site - West Jordan | West Jordan | Utah | 84088 | — |
| Velicept Investigative Site - Newport News | Newport News | Virginia | 23606 | — |
| Velicept Investigative Site - Norfolk | Norfolk | Virginia | 23507 | — |
| Velicept Investigative Site - Tacoma | Tacoma | Washington | 98405 | — |
| Velicept Investigative Site - Kenosha | Kenosha | Wisconsin | 53142 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03475706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03475706 live on ClinicalTrials.gov.